Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Scil Proteins, a biotech company specialized in the development and production of recombinant proteins, has completed a manufacturing agreement for Lundbeck.
Subscribe to our email newsletter
Scil Proteins took up the process development and early stage GMP manufacturing for a recombinant protein candidate.
Scil Proteins CEO Ulrike Fiedler said the company is happy that Lundbeck selected their protein manufacturing competence and facilities to deliver their protein.
Scil Proteins manufactures Boehringer Mannheim and Roche developed protein Reteplase for the treatment of myocardial infarction.